MedTrace Logo

The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia

NCT07364019 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2026-05-19

No results posted yet for this study

Summary

This study will recruit participants at risk for dementia to participate in an online educational program called Brain Health PRO (BHPro). The BHPro intervention is designed to address modifiable risk factors for dementia through a 6-month, fully online, educational program conveying the best available evidence for lifestyle changes that can mitigate dementia risk, and foster engagement toward one's own brain health. Achieving lifestyle changes in a diverse Canadian population through online education would be a major achievement in dementia prevention in Canada, with widespread personal and socioeconomic benefits.

Eligible participants will be randomly assigned to either start Brain Health PRO immediately or in 6 months (delayed-start control group). All participants will have the opportunity to have access to BHPro for 6 months during the course of the study and will have open access to all content for 12 months following the initial 6-month intervention. Participation will last from 18-24 months depending on group assignment.

Conditions

  • Dementia Prevention
  • Subjective Cognitive Impairment
  • Mild Cognitive Impairment
  • Cognitive Change
  • Lifestyle Intervention
  • Dementia Education

Interventions

OTHER

Brain Health PRO

Immediate start of 6-month Brain Health PRO Intervention

OTHER

Brain Health PRO

Delayed start of 6-month Brain Health PRO

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Alzheimer Society of Canada

    collaborator OTHER

  • Baycrest

    collaborator OTHER

  • The Canadian Consortium on Neurodegeneration in Aging (CCNA)

    collaborator UNKNOWN

  • University of British Columbia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-07
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07364019 on ClinicalTrials.gov